For instance, the phase 2 TIFA trial compare a ketogenic diet (<50g carbohydrate daily), a low carbohydrate diet (<100g carbohydrate daily), and SGLT2i for the treatment of hyperglycemia in patients with metastatic PIK3CA-mutant breast cancer on alpelisib (10). This evidence concerns the gene PIK3CA and Hyperglycemia.